Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Medical Devices — Distribution. Per the activity note to the FY2024 annual report, the company distributes and sells medical devices and consumable medical supplies. Sells medical consumables, instruments, tools, devices and similar products.
Subsidiary of Mega (100.0%)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,774 | 7,114 | 6,957 | 10,660 | 14,727 | 16,504 | 19,613 | +31.6% |
| Total COGS | 2,529 | 4,851 | 4,735 | 7,353 | 9,103 | 9,918 | 12,418 | +30.4% |
| Gross Profit | 1,246 | 2,262 | 2,222 | 3,307 | 5,624 | 6,586 | 7,196 | +34.0% |
| Gross Margin | 33.0% | 31.8% | 31.9% | 31.0% | 38.2% | 39.9% | 36.7% | |
| 377 | 620 | 636 | 1,016 | 1,468 | 2,185 | 3,067 | +41.8% | |
| EBITDA | 869 | 1,642 | 1,586 | 2,291 | 4,156 | 4,400 | 4,129 | +29.7% |
| EBITDA Margin | 23.0% | 23.1% | 22.8% | 21.5% | 28.2% | 26.7% | 21.1% | |
| Total D&A | 13 | 16 | 22 | 27 | 37 | 60 | 96 | +39.7% |
| EBIT / Operating Income | 856 | 1,626 | 1,563 | 2,264 | 4,119 | 4,341 | 4,033 | +29.5% |
| Total Interest Income | 16 | 21 | 32 | 22 | 74 | 145 | 50 | +20.4% |
| Total Interest Expense | 20 | 17 | 5 | 4 | 3 | 0 | 72 | +24.0% |
| 16 | 29 | 7 | 64 | 52 | 130 | 77 | +30.0% | |
| Profit Before Tax | 868 | 1,601 | 1,598 | 2,346 | 4,242 | 4,616 | 4,088 | +29.5% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 783 | 1,551 | 1,580 | 2,352 | 4,009 | 4,394 | 4,064 | +31.6% |
| Net Margin | 20.7% | 21.8% | 22.7% | 22.1% | 27.2% | 26.6% | 20.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.